sur Zomedica Corp. (NASDAQ:ZOM)
Zomedica Secures CE Mark for TRUVIEW Digital Microscope & Telepathology System
Zomedica Corp., a veterinary health company, has announced it has secured the CE Mark for its TRUVIEW™ digital microscopy and telepathology platform. This certification confirms the system's compliance with EU health, safety, and environmental standards. The approval opens commercialization opportunities for the TRUVIEW microscope across the European Economic Area.
The TRUVIEW platform boasts advanced diagnostic features such as LiquiView™ liquid lens technology and the proprietary TRUprep™ automated slide preparation system. This integrated solution enhances diagnostic accuracy and efficiency for veterinary professionals.
Bill Campbell, VP of Imaging at Zomedica, stated that the TRUVIEW microscope automates slide preparation and offers telepathology services, improving both precision and operational efficiency. The platform's telepathology feature allows real-time remote consultations, fostering collaboration among veterinary professionals.
CEO Larry Heaton emphasized that securing the CE Mark is a significant milestone for Zomedica, setting a new standard for veterinary diagnostics in Europe and globally.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Zomedica Corp.